Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | -2.81% | 177.01 | 0.7% | $1390.13m | |
| MRK | Merck & Co., Inc. | -2.60% | 91.96 | 0.7% | $1216.80m | |
| PFE | Pfizer Inc. | -2.29% | 50.69 | 0.9% | $1177.94m | |
| BMY | Bristol-Myers Squibb Co. | -1.58% | 78.72 | 1.0% | $1104.13m | |
| LLY | Eli Lilly & Co. | -2.91% | 317.75 | 1.1% | $1091.72m | |
| ABBV | AbbVie, Inc. | -0.40% | 152.53 | 1.9% | $989.13m | |
| AZN | AstraZeneca Plc | -0.87% | 65.93 | 1.0% | $446.77m | |
| SGEN | Seagen Inc. | 0.42% | 178.47 | 5.7% | $327.62m | |
| TPTX | Turning Point Therapeutics, Inc. | -0.28% | 75.06 | 0.0% | $295.90m | |
| GSK | GSK Plc | -0.78% | 43.36 | 0.2% | $285.09m | |
| HZNP | Horizon Therapeutics Plc | -4.45% | 81.69 | 5.4% | $176.63m | |
| NVS | Novartis AG | -1.27% | 84.20 | 0.2% | $166.38m | |
| MRTX | Mirati Therapeutics, Inc. | -1.67% | 68.50 | 1.6% | $162.75m | |
| NVO | Novo Nordisk A/S | -4.04% | 108.33 | 0.1% | $145.58m | |
| BHVN | Biohaven Pharmaceutical Holding Co. Ltd. | 0.47% | 144.69 | 0.0% | $142.13m |
Company Profile
Kura Oncology, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the research and development of medicines for the treatment of cancer. Its pipeline includes Tipifarnib, which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Chronic Myelomonocytic Leukemia, KO-947, which is an ERK inhibitor for MAPK Pathway Tumors, and KO-539, which is a Menin MLL inhibitor for acute leukemias. The company was founded by Troy E. Wilson, Yi Liu, Pingda Ren and Antonio Gualberto on August 22, 2014 and is headquartered in San Diego, CA.